Tore Bengtsson

Tore Bengtsson is a professor at the Department of Molecular Bioscience at the Wenner-Gren Institute, Stockholm University, known for his research on metabolic health, particularly in relation to type 2 diabetes and obesity. He has been involved in the development of a groundbreaking oral medication that enhances muscle metabolism, aiming to improve glucose control and promote fat burning without the side effects associated with existing appetite-suppressing drugs.